{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:23:15Z","timestamp":1776741795251,"version":"3.51.2"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T00:00:00Z","timestamp":1289347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s11095-010-0313-5","type":"journal-article","created":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T23:06:40Z","timestamp":1289344000000},"page":"934-937","source":"Crossref","is-referenced-by-count":265,"title":["The Phage Therapy Paradigm: Pr\u00eat-\u00e0-Porter or Sur-mesure?"],"prefix":"10.1007","volume":"28","author":[{"given":"Jean-Paul","family":"Pirnay","sequence":"first","affiliation":[]},{"given":"Daniel","family":"De Vos","sequence":"additional","affiliation":[]},{"given":"Gilbert","family":"Verbeken","sequence":"additional","affiliation":[]},{"given":"Maia","family":"Merabishvili","sequence":"additional","affiliation":[]},{"given":"Nina","family":"Chanishvili","sequence":"additional","affiliation":[]},{"given":"Mario","family":"Vaneechoutte","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Zizi","sequence":"additional","affiliation":[]},{"given":"Geert","family":"Laire","sequence":"additional","affiliation":[]},{"given":"Rob","family":"Lavigne","sequence":"additional","affiliation":[]},{"given":"Isabelle","family":"Huys","sequence":"additional","affiliation":[]},{"given":"Guy","family":"Van den Mooter","sequence":"additional","affiliation":[]},{"given":"Angus","family":"Buckling","sequence":"additional","affiliation":[]},{"given":"Laurent","family":"Debarbieux","sequence":"additional","affiliation":[]},{"given":"Flavie","family":"Pouillot","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Azeredo","sequence":"additional","affiliation":[]},{"given":"Elisabeth","family":"Kutter","sequence":"additional","affiliation":[]},{"given":"Alain","family":"Dublanchet","sequence":"additional","affiliation":[]},{"given":"Andrzej","family":"G\u00f3rski","sequence":"additional","affiliation":[]},{"given":"Revaz","family":"Adamia","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,11,10]]},"reference":[{"key":"313_CR1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pt.2009.11.009","volume":"26","author":"PD Williams","year":"2010","unstructured":"Williams PD. Darwinian interventions: taming pathogens through evolutionary ecology. Trends Parasitol. 2010;26:83\u201392.","journal-title":"Trends Parasitol."},{"key":"313_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nbt0104-31","volume":"22","author":"K Thiel","year":"2004","unstructured":"Thiel K. Old dogma, new tricks\u201421st Century phage therapy. Nat Biotechnol. 2004;22:31\u20136.","journal-title":"Nat Biotechnol."},{"key":"313_CR3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","volume":"45","author":"A Sulakvelidze","year":"2001","unstructured":"Sulakvelidze A, Alavidze Z, Morris Jr JG. Bacteriophage therapy. Antimicrob Agents Chemother. 2001;45:649\u201359.","journal-title":"Antimicrob Agents Chemother."},{"key":"313_CR4","volume-title":"Eliava Institute of Bacteriophage, Microbiology and Virology, Tbilisi, Georgia. A literature review of the practical application of bacteriophage research","author":"N Chanishvili","year":"2009","unstructured":"Chanishvili N, Sharp R. Eliava Institute of Bacteriophage, Microbiology and Virology, Tbilisi, Georgia. A literature review of the practical application of bacteriophage research. Tbilisi: Eliava Foundation; 2009."},{"key":"313_CR5","first-page":"766","volume":"10","author":"A G\u00f3rski","year":"2009","unstructured":"G\u00f3rski A, Miedzybrodzki R, Borysowski J, Weber-Dabrowska B, Lobocka M, Fortuna W, et al. Bacteriophage therapy for the treatment of infections. Curr Opin Investig Drugs. 2009;10:766\u201374.","journal-title":"Curr Opin Investig Drugs."},{"key":"313_CR6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/17460913.2.5.485","volume":"2","author":"G Verbeken","year":"2007","unstructured":"Verbeken G, De Vos D, Vaneechoutte M, Merabishvili M, Zizi M, Pirnay J-P. European regulatory conundrum of phage therapy. Future Microbiol. 2007;2:485\u201391.","journal-title":"Future Microbiol."},{"key":"313_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/138920110790725401","volume":"11","author":"E Kutter","year":"2010","unstructured":"Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, et al. Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol. 2010;11:69\u201386.","journal-title":"Curr Pharm Biotechnol."},{"key":"313_CR8","doi-asserted-by":"crossref","first-page":"e4944","DOI":"10.1371\/journal.pone.0004944","volume":"4","author":"M Merabishvili","year":"2009","unstructured":"Merabishvili M, Pirnay J-P, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, et al. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE. 2009;4:e4944.","journal-title":"PLoS ONE"},{"key":"313_CR9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1098\/rspb.2001.1945","volume":"269","author":"A Buckling","year":"2002","unstructured":"Buckling A, Rainey PB. Antagonistic coevolution between a bacterium and a bacteriophage. Proc Biol Sci. 2002;269:931\u20136.","journal-title":"Proc Biol Sci."},{"key":"313_CR10","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0264-410X(03)00073-2","volume":"21","author":"JM Wood","year":"2003","unstructured":"Wood JM, Levandowski RA. The influenza vaccine licensing process. Vaccine. 2003;21:1786\u20138.","journal-title":"Vaccine."},{"key":"313_CR11","unstructured":"Akst J. Key cancer patents killed. http:\/\/www.the-scientist.com\/blog\/display\/57265\/ (accessed 19\/10\/10), part of The Scientist. http:\/\/www.the-scientist.com\/ (accessed on 19\/10\/10)."},{"key":"313_CR12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrmicro822","volume":"2","author":"BR Levin","year":"2004","unstructured":"Levin BR, Bull JJ. Population and evolutionary dynamics of phage therapy. Nat Rev Microbiol. 2004;2:166\u201373.","journal-title":"Nat Rev Microbiol."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-010-0313-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-010-0313-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-010-0313-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:54:04Z","timestamp":1559368444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-010-0313-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,10]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["313"],"URL":"https:\/\/doi.org\/10.1007\/s11095-010-0313-5","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,10]]}}}